The Role of Fluoxetine and SSRIs in Motor Recovery Following Acute Ischaemic Stroke
single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo controlled cross-over pilot study, Restor Neurol Neurosci, 2007;25:143–50.
18. Rosser N, Heuschmann P, Wersching H, et al., Levodopa improves procedural motor learning in chronic stroke patients, Arch Phys Med Rehabil, 2008;89:1633–41.
19. Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke, Cochrane Database Syst Rev 2001;(4):CD000424.
20. Astrom M, Adolfsson R, Asplund K, Major depression in stroke patients: a 3-year longitudinal study, Stroke, 1993;24(7):976–82.
21. Berg A, Palomäki H, Lehtihalmes M, et al., Poststroke depression—an 18-month follow-up, Stroke, 2003;34(1):138–43.
22. Wiart L, Petit H, Joseph PA, et al., Fluoxetine in early post- stroke depression: a double-blind placebo-controlled study, Stroke, 2000;31:1829–32.
23. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U, Early fluoxetine treatment of post-stroke depression—a three-month double-blind placebo-controlled study with open-label long-
term follow up, J Neurol, 2003;250:347–51.
24. Hackett ML, Anderson CS, House A, Xia J, Interventions for treating depression after stroke, Cochrane Database Syst Rev, 2008;(4):CD003437.
25. Chen Y, Patel NC, Guo JJ, Zhan S, Antidepressant prophylaxis for poststroke depression: a meta-analysis, Int Clin Psychopharmacol, 2007;22(3):159–66.
26. Robinson RG, Jorge RE, Moser DJ, et al., Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial, JAMA, 2008;299:2391–400.
27. Hackett ML, Anderson CS, House A, Halteh C, Interventions for preventing depression after stroke, Cochrane Database Syst Rev, 2008;(3):CD003689.
28. Dam M, Tonin P, De Boni A, et al., Effects of fluoxetine and maprotiline on functional recovery in post stroke hemiplegic patients undergoing rehabilitation therapy, Stroke, 1996;27:1211–4.
29. Zittel S, Weiller C, Liepert J, Citalopram improves dexterity in chronic stroke patients, Neurorehabil Neural Repair, 2008;22:311–4.
30. Acler M, Robol E, Fiaschi A, Manganotti P, A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients, J Neurol, 2009;256:1152–8.
31. Mikami K, Jorge RE, Adams HP Jr, et al., Effect of antidepressants on the course of disability following stroke, Am J Geriatr Psychiatry, 2011;19:1007–15.
32. Pariente J, Loubinoux I, Carel C, et al., Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke, Ann Neurol, 2001;50:718–29.
33. Gerdelat-Mas A, Loubinoux I, Tombari D, et al., Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects, Neuroimage, 2005;27:314–22.
34. Chollet F, Tardy J, Albucher JF, et al., Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial, Lancet Neurol, 2011;10(2):123–30.
EUROPEAN NEUROLOGICAL REVIEW
253
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68